AF
Allegheny Financial Group
13F filer · CIK 0001844148Reported Jul 22, 2026
Net buyer this quarter
13F portfolio value$942MU.S. long equity reported on 13F
Positions20115 new · 12 closed
Net flow last quarter+$15.6MBuys minus sells
Top 10 positions weight15.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 22, 2026201 positions | |||||
| $22.9M | 2.43% | 0.00% | +2.3% | Q4 2020 | |
| $20.1M | 2.13% | 0.11% | -0.7% | Q4 2020 | |
| $20M | 2.12% | 1.71% | +20.0% | Q1 2025 | |
| $17.2M | 1.82% | 0.00% | -0.4% | Q4 2020 | |
| $15.7M | 1.67% | Not reported | Not reported | Q4 2020 | |
| $12.9M | 1.37% | Not reported | +2.6% | Q4 2020 | |
| $9.74M | 1.03% | 0.00% | +1.5% | Q4 2020 | |
| $9.63M | 1.02% | 0.04% | +0.2% | Q4 2020 | |
| $8.89M | 0.94% | 0.00% | +1.6% | Q4 2020 | |
| $7.04M | 0.75% | Not reported | +0.5% | Q4 2020 | |
| $6.53M | 0.69% | 0.01% | New | Q2 2026 | |
| $6.48M | 0.69% | 0.00% | -3.7% | Q4 2021 | |
| PPPRCSPraecis Pharmaceuticals Inc | $5.79M | 0.61% | Not reported | +23.4% | Q3 2025 |
| $5.49M | 0.58% | Not reported | +2.8% | Q4 2020 | |
| $5.24M | 0.56% | 0.05% | -0.1% | Q3 2024 | |
| $4.79M | 0.51% | 0.00% | +7.6% | Q4 2020 | |
| $3.97M | 0.42% | 0.00% | +2.5% | Q1 2021 | |
| $3.91M | 0.42% | 0.00% | 0.0% | Q3 2025 | |
| $3.86M | 0.41% | 0.00% | +1.0% | Q4 2020 | |
| $3.53M | 0.37% | 0.00% | +5.2% | Q4 2020 | |
| $3.51M | 0.37% | 0.00% | +12.2% | Q4 2020 | |
| $3.37M | 0.36% | 0.00% | +2.8% | Q4 2020 | |
| $3.25M | 0.35% | 0.00% | +30.3% | Q3 2023 | |
| $3.14M | 0.33% | 0.00% | +5.4% | Q4 2020 | |
| $2.8M | 0.30% | 0.00% | +4.5% | Q4 2020 | |
| $2.68M | 0.28% | Not reported | -2.4% | Q2 2021 | |
| $2.5M | 0.27% | 0.00% | +0.2% | Q4 2020 | |
| $2.29M | 0.24% | 0.00% | +1.8% | Q4 2020 | |
| $2.22M | 0.24% | 0.00% | +0.1% | Q4 2020 | |
| $2.2M | 0.23% | 0.00% | +0.3% | Q4 2020 | |
| $2.02M | 0.21% | 0.00% | +0.1% | Q4 2020 | |
| $1.87M | 0.20% | 0.00% | -0.8% | Q4 2020 | |
| $1.76M | 0.19% | Not reported | -5.0% | Q1 2026 | |
| $1.75M | 0.19% | 0.00% | +3.8% | Q4 2020 | |
| $1.71M | 0.18% | 0.00% | -0.2% | Q3 2021 | |
| $1.55M | 0.16% | 0.00% | +0.1% | Q4 2020 | |
| $1.54M | 0.16% | Not reported | +8.4% | Q4 2021 | |
| $1.51M | 0.16% | 0.00% | +1.3% | Q4 2020 | |
| $1.45M | 0.15% | Not reported | -6.9% | Q2 2022 | |
| $1.43M | 0.15% | 0.00% | +1.1% | Q4 2020 | |
| $1.42M | 0.15% | 0.00% | +2.2% | Q2 2024 | |
| $1.38M | 0.15% | 0.00% | -0.2% | Q4 2020 | |
| $1.36M | 0.14% | 0.00% | +7.5% | Q4 2020 | |
| $1.34M | 0.14% | 0.00% | +0.5% | Q4 2020 | |
| $1.34M | 0.14% | 0.00% | Not reported | Q4 2020 | |
| $1.34M | 0.14% | 0.00% | +6.6% | Q2 2021 | |
| $1.27M | 0.13% | 0.00% | +9.1% | Q4 2020 | |
| $1.24M | 0.13% | 0.00% | -0.2% | Q4 2020 | |
| $1.22M | 0.13% | 0.00% | +5.0% | Q4 2020 | |
| $1.19M | 0.13% | 0.00% | +6.0% | Q4 2020 | |
| Q1 2026Reported Apr 16, 2026196 positions | |||||
| $21.4M | 2.88% | 0.00% | -0.4% | Q4 2020 | |
| $19.6M | 2.65% | 0.00% | -1.3% | Q4 2020 | |
| $19.6M | 2.64% | 0.11% | -0.4% | Q4 2020 | |
| $16.5M | 2.22% | Not reported | Not reported | Q4 2020 | |
| $14.5M | 1.95% | 1.43% | +64.0% | Q1 2025 | |
| $12M | 1.62% | Not reported | +0.1% | Q4 2020 | |
| $8.68M | 1.17% | 0.00% | +1.2% | Q4 2020 | |
| $8.47M | 1.14% | 0.04% | +0.4% | Q4 2020 | |
| $7.36M | 0.99% | 0.00% | -0.1% | Q4 2020 | |
| $6.1M | 0.82% | Not reported | 0.0% | Q4 2020 | |
| $6.06M | 0.82% | 0.05% | -0.1% | Q3 2024 | |
| $4.48M | 0.60% | 0.00% | +0.5% | Q4 2021 | |
| $4.33M | 0.58% | Not reported | +0.4% | Q4 2020 | |
| PPPRCSPraecis Pharmaceuticals Inc | $4.07M | 0.55% | Not reported | +16.8% | Q3 2025 |
| $3.58M | 0.48% | 0.00% | -4.2% | Q4 2020 | |
| $3.57M | 0.48% | 0.00% | 0.0% | Q4 2020 | |
| $3.48M | 0.47% | 0.00% | +1.4% | Q3 2025 | |
| $3.18M | 0.43% | 0.00% | +0.8% | Q1 2021 | |
| $2.94M | 0.40% | 0.00% | +0.2% | Q4 2020 | |
| $2.89M | 0.39% | 0.00% | -0.3% | Q4 2020 | |
| $2.74M | 0.37% | 0.00% | -0.9% | Q4 2020 | |
| $2.58M | 0.35% | 0.00% | +0.6% | Q4 2020 | |
| $2.52M | 0.34% | 0.00% | +0.2% | Q4 2020 | |
| $2.43M | 0.33% | Not reported | +6.8% | Q2 2021 | |
| $2.28M | 0.31% | 0.00% | -0.2% | Q4 2020 | |
| $2.22M | 0.30% | 0.00% | +0.4% | Q4 2020 | |
| $2.18M | 0.29% | 0.00% | -1.9% | Q3 2023 | |
| $2M | 0.27% | 0.00% | +0.3% | Q4 2020 | |
| $1.98M | 0.27% | 0.00% | +0.3% | Q4 2020 | |
| $1.97M | 0.27% | 0.00% | -0.1% | Q4 2020 | |
| $1.93M | 0.26% | 0.00% | -0.6% | Q4 2020 | |
| $1.9M | 0.26% | 0.00% | -1.6% | Q4 2020 | |
| $1.77M | 0.24% | 0.00% | +1.1% | Q4 2020 | |
| $1.75M | 0.24% | Not reported | New | Q1 2026 | |
| $1.68M | 0.23% | 0.00% | +0.3% | Q4 2020 | |
| $1.49M | 0.20% | Not reported | +3.0% | Q2 2022 | |
| $1.46M | 0.20% | 0.00% | -0.2% | Q4 2020 | |
| $1.4M | 0.19% | 0.00% | -2.2% | Q4 2020 | |
| $1.4M | 0.19% | 0.00% | +4.8% | Q4 2020 | |
| $1.38M | 0.19% | 0.00% | Not reported | Q4 2020 | |
| $1.37M | 0.19% | 0.00% | +0.3% | Q4 2020 | |
| $1.3M | 0.18% | 0.00% | +0.6% | Q3 2021 | |
| $1.29M | 0.17% | 0.00% | -1.6% | Q4 2020 | |
| $1.29M | 0.17% | 0.00% | -1.2% | Q3 2023 | |
| $1.27M | 0.17% | 0.00% | +1.3% | Q4 2020 | |
| $1.23M | 0.17% | 0.00% | 0.0% | Q2 2021 | |
| $1.22M | 0.17% | 0.00% | +1.4% | Q4 2020 | |
| $1.2M | 0.16% | 0.00% | +0.9% | Q4 2020 | |
| $1.15M | 0.16% | 0.00% | +0.5% | Q4 2020 | |
| $1.11M | 0.15% | 0.00% | +0.6% | Q4 2020 | |
| Q4 2025Reported Feb 2, 2026196 positions | |||||
| $21.8M | 3.22% | 0.11% | -0.3% | Q4 2020 | |
| $21.3M | 3.15% | 0.00% | +0.5% | Q4 2020 | |
| $18.8M | 2.79% | Not reported | 0.0% | Q4 2020 | |
| $15.2M | 2.26% | 0.00% | +0.2% | Q4 2020 | |
| $12.6M | 1.87% | Not reported | -2.3% | Q4 2020 | |
| $11.2M | 1.66% | 0.00% | -0.8% | Q4 2020 | |
| $9.39M | 1.39% | 0.87% | +100.9% | Q1 2025 | |
| $8.6M | 1.27% | 0.00% | -0.8% | Q4 2020 | |
| $8.09M | 1.20% | 0.04% | +12.1% | Q4 2020 | |
| $7.83M | 1.16% | 0.04% | +1.2% | Q3 2024 | |
| $6.4M | 0.95% | Not reported | +0.2% | Q4 2020 | |
| $4.72M | 0.70% | Not reported | -4.0% | Q4 2020 | |
| $4.07M | 0.60% | 0.00% | -2.2% | Q4 2020 | |
| $4.07M | 0.60% | 0.00% | -48.2% | Q3 2025 | |
| PPPRCSPraecis Pharmaceuticals Inc | $3.75M | 0.55% | Not reported | +313.7% | Q3 2025 |
| $3.61M | 0.53% | 0.00% | -0.1% | Q4 2021 | |
| $3.55M | 0.52% | 0.00% | -0.3% | Q4 2020 | |
| $3.52M | 0.52% | 0.00% | -0.1% | Q1 2021 | |
| $3.22M | 0.48% | 0.00% | +0.5% | Q4 2020 | |
| $3.13M | 0.46% | 0.00% | +0.5% | Q4 2020 | |
| $3.06M | 0.45% | 0.00% | -2.9% | Q4 2020 | |
| $2.52M | 0.37% | 0.00% | -7.3% | Q4 2020 | |
| $2.37M | 0.35% | 0.00% | +7.0% | Q3 2023 | |
| $2.22M | 0.33% | 0.00% | +0.1% | Q4 2020 | |
| $2.21M | 0.33% | Not reported | +54.6% | Q2 2021 | |
| $2.2M | 0.32% | 0.00% | -4.7% | Q4 2020 | |
| $2.17M | 0.32% | 0.00% | +0.1% | Q4 2020 | |
| $2.02M | 0.30% | 0.00% | -2.1% | Q4 2020 | |
| $1.98M | 0.29% | 0.00% | -0.1% | Q4 2020 | |
| $1.88M | 0.28% | 0.00% | +0.1% | Q4 2020 | |
| BMBYMBlackRock Municipal Income Quality Trust | $1.84M | 0.27% | Not reported | +0.2% | Q2 2022 |
| $1.73M | 0.26% | 0.00% | -1.6% | Q4 2020 | |
| $1.66M | 0.25% | 0.00% | -1.7% | Q1 2021 | |
| $1.47M | 0.22% | 0.00% | +0.3% | Q4 2020 | |
| $1.45M | 0.21% | 0.00% | +0.1% | Q4 2020 | |
| $1.45M | 0.21% | 0.00% | +473.4% | Q2 2021 | |
| $1.43M | 0.21% | Not reported | +13.5% | Q2 2022 | |
| $1.42M | 0.21% | 0.00% | -0.8% | Q4 2020 | |
| $1.41M | 0.21% | 0.00% | 0.0% | Q3 2021 | |
| $1.35M | 0.20% | 0.00% | -3.4% | Q4 2020 | |
| $1.29M | 0.19% | 0.00% | +3.8% | Q4 2020 | |
| $1.27M | 0.19% | 0.00% | -0.2% | Q4 2020 | |
| $1.23M | 0.18% | Not reported | +6.9% | Q4 2021 | |
| $1.22M | 0.18% | 0.00% | -5.5% | Q4 2020 | |
| $1.17M | 0.17% | 0.00% | +5.4% | Q3 2023 | |
| $1.14M | 0.17% | 0.00% | -1.8% | Q4 2020 | |
| $1.13M | 0.17% | 0.00% | +0.2% | Q4 2020 | |
| $1.12M | 0.17% | 0.00% | +1.5% | Q4 2020 | |
| $1.11M | 0.16% | 0.00% | 0.0% | Q4 2020 | |
| $1.09M | 0.16% | 0.00% | -4.4% | Q3 2022 | |
| Q3 2025Reported Nov 6, 2025189 positions | |||||
| $24M | 4.49% | 0.10% | -0.6% | Q4 2020 | |
| $20.9M | 3.90% | Not reported | 0.0% | Q4 2020 | |
| $19.8M | 3.71% | 0.00% | -1.1% | Q4 2020 | |
| $14.3M | 2.66% | 0.00% | -0.6% | Q4 2020 | |
| $12.9M | 2.41% | Not reported | +0.6% | Q4 2020 | |
| $12.1M | 2.26% | 0.00% | +0.7% | Q4 2020 | |
| $10.1M | 1.89% | 0.04% | +2.5% | Q3 2024 | |
| $8.25M | 1.54% | 0.01% | New | Q3 2025 | |
| $7.4M | 1.38% | 0.03% | 0.0% | Q4 2020 | |
| $6.24M | 1.17% | Not reported | +22.8% | Q4 2020 | |
| $6.16M | 1.15% | 0.00% | +0.1% | Q4 2020 | |
| $4.4M | 0.82% | 0.43% | +46.7% | Q1 2025 | |
| $3.81M | 0.71% | Not reported | -1.2% | Q4 2020 | |
| $3.39M | 0.63% | 0.00% | -0.4% | Q4 2020 | |
| $3.36M | 0.63% | 0.00% | -0.9% | Q1 2021 | |
| $3.23M | 0.60% | 0.00% | -1.8% | Q4 2020 | |
| $3.13M | 0.59% | 0.00% | +0.2% | Q4 2020 | |
| $3.01M | 0.56% | 0.00% | +21.9% | Q4 2021 | |
| $3M | 0.56% | 0.00% | +1.0% | Q4 2020 | |
| $2.61M | 0.49% | 0.00% | +1.4% | Q4 2020 | |
| $2.48M | 0.46% | 0.00% | -3.1% | Q4 2020 | |
| $2.47M | 0.46% | 0.00% | -4.7% | Q4 2020 | |
| $2.24M | 0.42% | 0.00% | +0.1% | Q4 2020 | |
| $2.22M | 0.41% | 0.00% | -0.8% | Q3 2023 | |
| $2.09M | 0.39% | 0.00% | -3.2% | Q4 2020 | |
| $2.01M | 0.37% | 0.00% | -0.7% | Q4 2020 | |
| $1.94M | 0.36% | 0.00% | -8.4% | Q4 2020 | |
| $1.92M | 0.36% | 0.00% | +32.5% | Q4 2020 | |
| $1.89M | 0.35% | 0.00% | +0.4% | Q4 2020 | |
| BMBYMBlackRock Municipal Income Quality Trust | $1.84M | 0.34% | Not reported | -0.3% | Q2 2022 |
| $1.73M | 0.32% | 0.00% | -0.1% | Q1 2021 | |
| $1.55M | 0.29% | 0.00% | +6.8% | Q4 2020 | |
| $1.5M | 0.28% | 0.00% | +0.2% | Q4 2020 | |
| $1.48M | 0.28% | 0.00% | -0.3% | Q4 2020 | |
| $1.41M | 0.26% | Not reported | +13.5% | Q2 2021 | |
| $1.37M | 0.26% | 0.00% | -0.2% | Q3 2021 | |
| $1.37M | 0.26% | 0.00% | +2.9% | Q2 2021 | |
| $1.32M | 0.25% | 0.00% | -16.5% | Q4 2020 | |
| $1.32M | 0.25% | 0.00% | +0.1% | Q4 2020 | |
| $1.31M | 0.24% | 0.00% | 0.0% | Q4 2020 | |
| $1.3M | 0.24% | 0.00% | -0.1% | Q4 2020 | |
| $1.3M | 0.24% | 0.00% | +4.2% | Q4 2020 | |
| $1.25M | 0.23% | 0.00% | -0.3% | Q4 2020 | |
| $1.24M | 0.23% | Not reported | +19.8% | Q2 2022 | |
| $1.19M | 0.22% | 0.00% | -1.9% | Q4 2020 | |
| $1.12M | 0.21% | Not reported | -0.5% | Q4 2021 | |
| $1.12M | 0.21% | 0.00% | -0.2% | Q4 2020 | |
| $1.12M | 0.21% | 0.00% | -3.4% | Q4 2020 | |
| $1.12M | 0.21% | 0.00% | -0.4% | Q4 2020 | |
| $1.11M | 0.21% | Not reported | -2.1% | Q2 2023 | |
Premium opens every quarter this fund has filed